scispace - formally typeset
F

Frederic H. Fahey

Researcher at Boston Children's Hospital

Publications -  182
Citations -  5899

Frederic H. Fahey is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Population & Imaging phantom. The author has an hindex of 35, co-authored 179 publications receiving 5221 citations. Previous affiliations of Frederic H. Fahey include Georgetown University Medical Center & Harvard University.

Papers
More filters
Journal ArticleDOI

Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment

TL;DR: In lipoatrophic A-ZIP/F1 ‘fatless’ mice, and in mice treated with the peroxisome proliferator-activated receptor-γ inhibitor bisphenol A diglycidyl ether, marrow engraftment after irradiation is accelerated relative to wild-type or untreated mice, suggesting that antagonizing marrow adipogenesis may enhance haematopoietic recovery in clinical bone-marrow transplantation.
Journal ArticleDOI

Skeletal PET with 18F-Fluoride: Applying New Technology to an Old Tracer

TL;DR: The favorable imaging performance and the clinical utility of 18F-fluoride PET, compared with 99mTc-diphosphonate scintigraphy, support the reconsideration of 18f- fluoride as a routine bone-imaging agent.
Journal ArticleDOI

Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease

TL;DR: This model reproduces many of the defining features of human osteosarcoma including cytogenetic complexity and comparable gene expression signatures, histology, and metastatic behavior and provides a valuable platform for addressing the molecular genetics of osteosARcoma and for developing novel therapeutic strategies.
Journal ArticleDOI

The voltage-gated proton channel Hv1 enhances brain damage from ischemic stroke

TL;DR: Results indicate that Hv1-dependent ROS production is responsible for a substantial fraction of brain damage at early time points after ischemic stroke and provide a rationale for Hv 1 as a therapeutic target for the treatment of isChemic stroke.
Journal ArticleDOI

Dexmedetomidine-Induced Sedation in Volunteers Decreases Regional and Global Cerebral Blood Flow

TL;DR: Hemodynamic and CBF (via positron emission tomography) measurements were determined at each experimental time point and dexmedetomidine decreased both cardiac output and heart rate during and 30 min after drug administration.